Mineralys Therapeutics (MLYS) Profit After Tax (2022 - 2026)
Quarterly results put Profit After Tax at -$39.3 million for Q1 2026, up 6.8% from a year ago — trailing twelve months through Mar 2026 was -$151.8 million (up 19.48% YoY), and the annual figure for FY2025 was -$154.7 million, up 13.02%.
Mineralys Therapeutics has reported Profit After Tax over the past 5 years, most recently at -$39.3 million for Q1 2026.
- Profit After Tax reached -$39.3 million in Q1 2026 per MLYS's latest filing, down from -$32.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$6.5 million in Q2 2022 and bottomed at -$56.3 million in Q3 2024.
- Median Profit After Tax over the past 5 years was -$31.5 million (2024), compared with a mean of -$27.9 million.
- The largest annual shift saw Profit After Tax plummeted 240.82% in 2023 before it skyrocketed 34.45% in 2025.
- Over 5 years, Profit After Tax stood at -$9.1 million in 2022, then crashed by 168.81% to -$24.4 million in 2023, then tumbled by 100.69% to -$48.9 million in 2024, then skyrocketed by 34.11% to -$32.3 million in 2025, then dropped by 21.98% to -$39.3 million in 2026.
- Business Quant data shows Profit After Tax for MLYS at -$39.3 million in Q1 2026, -$32.3 million in Q4 2025, and -$36.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -39.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.34 Mn |
| Dec 31, 2025 | -32.25 Mn |
| Sep 30, 2025 | -36.93 Mn |
| Jun 30, 2025 | -43.27 Mn |
| Mar 31, 2025 | -42.21 Mn |
| Dec 31, 2024 | -48.95 Mn |
| Sep 30, 2024 | -56.34 Mn |
| Jun 30, 2024 | -41.01 Mn |
| Mar 31, 2024 | -31.51 Mn |
| Dec 31, 2023 | -24.39 Mn |
| Sep 30, 2023 | -22.76 Mn |
| Jun 30, 2023 | -12.14 Mn |
| Mar 31, 2023 | -12.61 Mn |
| Dec 31, 2022 | -9.07 Mn |
| Sep 30, 2022 | -6.68 Mn |
| Jun 30, 2022 | -6.48 Mn |
| Mar 31, 2022 | -7.57 Mn |